Serum and synovial fluid osteocalcin in rheumatic diseases

Area of Science:

• Rheumatology
• Orthopedics
• Biochemistry

Background:

• Juxta-articular bone destruction mechanisms in inflammatory arthritis are not well understood.
• Osteocalcin (gamma-carboxyglutamic acid protein) is a key marker for osteoblastic bone formation.
• Serum osteocalcin variations in rheumatisms like rheumatoid arthritis require further investigation.

Purpose of the Study:

• To investigate local osteoblastic activity by measuring osteocalcin levels in synovial fluid.
• To compare serum and synovial fluid osteocalcin levels in inflammatory arthritis versus mechanical joint effusion.
• To explore the relationship between synovial fluid osteocalcin and inflammatory markers.

Main Methods:

• Radioimmunoassay was used to measure osteocalcin levels in paired serum and synovial fluid samples.
• 63 patients were analyzed: 33 with inflammatory arthritis and 30 with mechanical joint effusion.
• Synovial fluid cell counts were correlated with osteocalcin levels.

Main Results:

• Serum osteocalcin levels were comparable between inflammatory and mechanical groups.
• Synovial fluid osteocalcin levels were significantly lower in the inflammatory arthritis group (3.27 ng/ml) compared to the mechanical group (6.91 ng/ml).
• A significant inverse correlation was found between synovial fluid osteocalcin and synovial fluid cell counts.

Conclusions:

• The study suggests periarticular osteoblastic depression in patients with inflammatory arthritis.
• Lower intra-articular osteocalcin may contribute to juxta-articular bone destruction in inflammatory conditions.
• Osteocalcin assays in synovial fluid offer insights into local bone metabolism in joint diseases.